Filing Details
- Accession Number:
- 0001127602-11-017747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-27 16:13:36
- Reporting Period:
- 2011-05-26
- Filing Date:
- 2011-05-27
- Accepted Time:
- 2011-05-27 15:13:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1265751 | Nancy Leaming | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-26 | 25,000 | $55.97 | 33,820 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-05-26 | 2,200 | $55.97 | 36,020 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-05-26 | 5,975 | $53.43 | 41,995 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-26 | 28,544 | $92.98 | 13,451 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-26 | 4,631 | $93.50 | 8,820 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-26 | 25,000 | $0.00 | 25,000 | $55.97 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-26 | 2,200 | $0.00 | 2,200 | $55.97 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-26 | 5,975 | $0.00 | 5,975 | $53.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2018-01-08 | No | 4 | M | Direct | |
| 0 | 2009-01-08 | 2018-01-08 | No | 4 | M | Direct |
| 0 | 2010-06-03 | 2019-06-02 | No | 4 | M | Direct |
Footnotes
- Exercise/Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $92.41 (low) and $93.40 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $93.41 (low) and $93.60 (high).
- The stock options become exercisable in three (3) equal annual installments, commencing one year after the grant date of 01/08/2008.
- Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).
Billionaire Hedge Funds
